Opioid abuse began in the late 1990s and was reported to be a health problem in 2017. For years, HealthPartners Institute research groups have looked for ways to fight this growing disease.
Our intervention was more critical because of the significant increase in opioid use during COVID-19 disease. Data from the Minnesota Department of Health showed a 55% increase in opioid overdose deaths in the first six months of 2020, compared to the same period in 2019.
“We’re seeing the effects of COVID therapy on opioid addiction,” said Rebecca Rossom, MD, lead researcher at the HealthPartners Institute. “The rise in overdoses is being led by synthetic opioids, especially fentanyl.”
But these deaths can be prevented, Dr. Rossom said. And he and his team at the Institute are launching a new tool called the “Opioid Wizard” to help identify people with opioid use disorders (OUD) and overdose.
How the Opioid Wizard works magic
The Opioid Wizard is built on our Priorities Wizard Clinical Decision Support platform, helping physicians more easily identify patients ’critical times in order to improve their health and well -being.
The platform uses sophisticated algorithms to take medical records and referral electronic medical record (EHR) and flagging to patients suffering from OUD or overdose. By making patients aware of certain conditions, such as opioid counseling in the past, physicians can provide the best possible care during the physician’s time.
If a person has a serious problem, the Opioid Wizard will require doctors to check their patient for OUD. It has OUD treatment options, as well as appropriate medications. In some cases, the doctor may be advised to prescribe a naloxone injection. Naloxone is a drug used to treat opioid overdose.
It uses information to give hope and improve lives
The “Wizard” technology has been tested in other areas, such as cardiology, and has previously provided reliable results for patients.
For example, the Cardiovascular Wizard helped identify patients who could benefit from certain cardiovascular medications by diagnosing complications such as blood pressure, smoking status and physical score. . The data show that this tool has helped reduce the 10 -year risk of heart disease by 2%.
Now, we hope that the same technology can help us deal with the outcome of the opioid crisis with early OUD and overdose treatment.
Within two years, Drs. Rossom and his team will study the results from 30 pleasure clinics to see if the manufacturer has an impact on medical care and outcomes. They will evaluate changes in OUD patients, emergency room orders, OUD medications, emergency business visits, hospitalizations and other outcomes. The research will be conducted in collaboration with Essentia Health and Geisinger health systems.
“If we could start patients with OUD on medications, mortality would be reduced by 50%,” Drs. Rossom said. “There are few practices in health care that significantly improve the outcomes of death. The Opioid Wizard aims to improve access to treatment for patients with OUD.